Milestone Scientific
Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally. It operates through Dental and Medical segments. The company provides the Wand, a single use disposable handpiece device for dental procedures that requ… Read more
Milestone Scientific (MLSS) - Total Assets
Latest total assets as of September 2025: $8.49 Million USD
Based on the latest financial reports, Milestone Scientific (MLSS) holds total assets worth $8.49 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Milestone Scientific - Total Assets Trend (1996–2024)
This chart illustrates how Milestone Scientific’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Milestone Scientific - Asset Composition Analysis
Current Asset Composition (December 2024)
Milestone Scientific's total assets of $8.49 Million consist of 94.8% current assets and 5.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 33.3% |
| Accounts Receivable | $475.38K | 4.9% |
| Inventory | $3.71 Million | 37.9% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $148.40K | 1.5% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1996–2024)
This chart illustrates how Milestone Scientific's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Milestone Scientific's current assets represent 94.8% of total assets in 2024, an increase from 34.0% in 1996.
- Cash Position: Cash and equivalents constituted 33.3% of total assets in 2024, up from 17.0% in 1996.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, a decrease from 42.0% in 1996.
- Asset Diversification: The largest asset category is inventory at 37.9% of total assets.
Milestone Scientific Competitors by Total Assets
Key competitors of Milestone Scientific based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
|
China | CN¥3.82 Billion |
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥16.46 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥28.98 Billion |
|
Allmed Medical Products Co Ltd Class A
SHE:002950
|
China | CN¥5.35 Billion |
|
Inix Technologies Holdings Bhd
KLSE:0094
|
Malaysia | RM72.53 Million |
|
Focus Point Holdings Bhd
KLSE:0157
|
Malaysia | RM328.19 Million |
|
Careplus Group Bhd
KLSE:0163
|
Malaysia | RM286.61 Million |
|
LKL International Bhd
KLSE:0182
|
Malaysia | RM173.46 Million |
Milestone Scientific - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Milestone Scientific generates 0.88x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Milestone Scientific is currently not profitable relative to its asset base.
Milestone Scientific - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.61 | 2.85 | 6.45 |
| Quick Ratio | 0.79 | 1.86 | 5.61 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $3.08 Million | $ 6.94 Million | $ 15.68 Million |
Milestone Scientific - Advanced Valuation Insights
This section examines the relationship between Milestone Scientific's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 8.05 |
| Latest Market Cap to Assets Ratio | 1.77 |
| Asset Growth Rate (YoY) | -13.8% |
| Total Assets | $9.80 Million |
| Market Capitalization | $17.30 Million USD |
Valuation Analysis
Above Book Valuation: The market values Milestone Scientific's assets above their book value (1.77 x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: Milestone Scientific's assets decreased by 13.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Milestone Scientific (1996–2024)
The table below shows the annual total assets of Milestone Scientific from 1996 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $9.80 Million | -13.85% |
| 2023-12-31 | $11.37 Million | -17.01% |
| 2022-12-31 | $13.70 Million | -30.83% |
| 2021-12-31 | $19.81 Million | +1.22% |
| 2020-12-31 | $19.57 Million | +198.51% |
| 2019-12-31 | $6.56 Million | +2.43% |
| 2018-12-31 | $6.40 Million | -59.04% |
| 2017-12-31 | $15.63 Million | +15.34% |
| 2016-12-31 | $13.55 Million | +5.79% |
| 2015-12-31 | $12.81 Million | -26.71% |
| 2014-12-31 | $17.48 Million | +116.97% |
| 2013-12-31 | $8.06 Million | +42.29% |
| 2012-12-31 | $5.66 Million | -19.04% |
| 2011-12-31 | $6.99 Million | +5.80% |
| 2010-12-31 | $6.61 Million | +36.27% |
| 2009-12-31 | $4.85 Million | +9.96% |
| 2008-12-31 | $4.41 Million | -11.60% |
| 2007-12-31 | $4.99 Million | -2.96% |
| 2006-12-31 | $5.14 Million | -27.07% |
| 2005-12-31 | $7.05 Million | +31.29% |
| 2004-12-31 | $5.37 Million | +212.81% |
| 2003-12-31 | $1.72 Million | +38.35% |
| 2002-12-31 | $1.24 Million | -18.14% |
| 2001-12-31 | $1.52 Million | -40.65% |
| 2000-12-31 | $2.55 Million | -54.58% |
| 1999-12-31 | $5.62 Million | -38.89% |
| 1998-12-31 | $9.20 Million | -54.00% |
| 1997-12-31 | $20.00 Million | +325.53% |
| 1996-12-31 | $4.70 Million | -- |